ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · Real-Time Price · USD
1.005
-0.005 (-0.50%)
At close: Jun 20, 2025, 4:00 PM
0.9611
-0.0440 (-4.37%)
After-hours: Jun 20, 2025, 7:54 PM EDT
ImmunoPrecise Antibodies Market Cap
ImmunoPrecise Antibodies has a market cap or net worth of $45.99 million as of June 20, 2025. Its market cap has increased by 60.26% in one year.
Market Cap
45.99M
Enterprise Value
46.00M
1-Year Change
60.26%
Ranking
Category
Stock Price
$1.01
Market Cap Chart
Since December 31, 2020, ImmunoPrecise Antibodies's market cap has decreased from $250.60M to $45.99M, a decrease of -81.65%. That is a compound annual growth rate of -31.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 33.20M | 196.43% |
| Dec 31, 2024 | 11.20M | -73.83% |
| Dec 29, 2023 | 42.80M | -67.05% |
| Dec 30, 2022 | 129.90M | 25.14% |
| Dec 31, 2021 | 103.80M | -58.58% |
| Dec 31, 2020 | 250.60M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.97B |
| Johnson & Johnson | 360.07B |
| Novo Nordisk | 333.14B |
| AbbVie | 327.38B |
| UnitedHealth Group | 278.76B |
| Abbott Laboratories | 230.16B |
| Novartis AG | 227.73B |
| AstraZeneca | 219.65B |